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Unilateral leukemic infiltration and acute angle closure
as the first sign of B-cell acute lymphoblastic leukemia
relapse
Abstract
Objective: Unilateral ocular leukemic infiltration with acute angle closure
is an infrequent complication of B-cell acute lymphoblastic leukemia
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Mafalda Mota1(ALL-B). We present a clinical case of leukemic ocular infiltration as the
sole manifestation of ALL-B relapse. Andreia Bilé
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Results: A 15-year-old female with a history of acute lymphoblastic
leukemia in remission for 2 years and pulmonary tuberculosis treated
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Graça Pires1in the past year presented with ocular redness and decreased visual
Susana Teixeira1acuity in the left eye (LE) with 5 days of evolution. Visual acuity was
20/20 in the right eye (RE) and absence of light perception in the left Isabel Prieto1
eye (LE). Biomicroscopy of LE showed a small hypopion, anterior
chamber cells 4+, vitreous cells 3+, and a large white mass in the vit-
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reous with associated vitreous hemorrhage in organization. In LE fundo-
scopy, the vitreous mass occupying most of the vitreous cavity and as-
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sociated hemorrhage prevented retina visualization. B-scan ultrasound
showed a multilobulated mass occupying virtually the entire vitreous
cavity with associated choroidal detachment. Forty-eight hours later, 2 Hospital Prof. Dr. Fernando
Fonseca E.P.E., Pediatricshe developed acute angle closure of LE with an IOP of 55 mmHg. A
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flow cytometric analysis of the anterior chamber and vitreous showed
leukemic tumor cells. Themicrobiologic exam and PCR forMycobacteri-
um tuberculosiswere negative. No other signs of relapse of the disease
were identified after investigation by the oncology department. Rescue
treatment of the underlying disease was started, with symptomatic im-
provement.
Conclusion: Leukemic ocular infiltration can be the only manifestation
of ALL-B relapse.
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Introduction
Ophthalmic manifestations of leukemia have been de-
scribed previously in literature and can occur in 9 to 90%
of patients, mostly with retinal involvement [1], [2], [3].
Ophthalmic signs can be observed at the onset of disease
or during follow-up [3], typically manifesting bilaterally
and symmetrically [4]. However, it is uncommon that a
relapsed disease presents solely with ocular manifesta-
tions [1], [4], [5]. We present a clinical case of unilateral
leukemic ocular infiltration with choroidal infiltration and
subsequent angle closure as the sole manifestation of
ALL-B relapse.
Case description
We present the case of a 15-year old girl with a history
of B-cell acute lymphoblastic leukemia (t(1:19)) in clinical
remission for two years. She was under maintenance
chemotherapy with dexamethasone, mercaptopurine,
and melphalan. In the past year, she was also suffering
from pulmonary tuberculosis having completed 9months
of therapy. She presented in our ophthalmology emer-
gency room with acute visual loss of the left eye (LE) and
ocular redness for 5 days. Best corrected visual acuity in
her RE was 20/20 and absence of light perception in her
left eye (LE). Intraocular pressure upon presentation was
12mmHg in RE and 22mmHg in LE. In LE biomicroscopy,
she presented with a very small hypopyon, small, inferior,
keratic precipitates, anterior chamber cells 4+, vitreous
cells 3+, and a dense white mass was visible in the vit-
reous cavity along with organized vitreous hemorrhage
(Figure 1). The fundoscopy examinationwasmade difficult
by the dense vitritis. It was possible to perceive the
presence of a white vitreous mass occupying most of the
vitreous cavity and vitreous hemorrhage. Biomicroscopy
and fundoscopy were normal in LE. B-scan ultrasound
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Figure 1: Biomicroscopy of the left eye showed a very small hypopyon, small, inferior, keratic precipitates, anterior chamber
cells 4+, vitreous cells 3+, and a dense white mass was visible in the vitreous cavity along with organized vitreous hemorrhage.
showed a multilobulated vitreous mass occupying prac-
tically the entire ocular globe with associated superior
choroidal detachment (Figure 2). An orbital and cranial
MRI revealed an intraocular mass with gadolinium
enhancement and lacrimal gland enlargement (Figure 3).
Figure 2: B-scan ultrasound of the left eye showing a
multilobulated vitreous mass occupying practically the entire
ocular globe with associated superior choroidal detachment
The patient wasmedicated with an association of Timolol
1% and Dorzolomide 1% bid as well as topical Dexa-
methasone 1% qid. Two days later, she suffered clinical
worsening with severe ocular pain, headache, and naus-
ea. IOP was now 55 mmHg in LE and the biomicroscopy
of LE showed a shallow anterior chamber. Acute angle
closure was diagnosed, andwe added topical Brimonidine
0.1% bid and Acetazolamide 500mg qid to her therapeu-
tic scheme. A flow cytometry analysis of the aqueous
humor and vitreous revealed ALL-B cells sharing the im-
munophenotype with previously diagnosed leukemic cells
(CD34–/CD10+/CD19+/CD20+weak/CD38+).Microbio-
logic analysis was negative for bacteria and fungus as
well as the PCR study for Mycobacterium tuberculosis.
Ocular relapse of B-cell ALL was diagnosed. The patient
was re-staged but there were no signs of relapse in the
bone marrow, the central nervous system or any other
systemic location. Radiotherapy (30Gy) and rescue che-
motherapy (INTREALL HR) were started with symptomatic
improvement and better IOP control even though the pa-
Figure 3: Orbital and cranial MRI revealed an intraocular mass
with gadoliniumenhancement and lacrimal gland enlargement.
No signs of CNS metastasis were found.
tient was still under topical hypotensive drugs. Final MAVC
was absence of light perception and 8 months after
presentation, the patient remained without any other
signs of systemic relapse.
Discussion
We present a case of unilateral leukemic infiltration as
the sole manifestation of relapsed ALL-B. Though, infre-
quent, unilateral eye involvement as the first sign of
leukemic relapse has been described previously in the
literature [2], [5], [6], [7]. Our patient presented with an
intraocular mass occupying the entire vitreous cavity with
associated vitreous hemorrhage and choroidal detach-
ment. Forty-eight hours after presenting in our emergency
room, the patient evolved to acute angle closure with an
IOP of 55 mmHg, secondary to the pushing effect on the
iris of the very extensive vitreous mass and associated
choroidal detachment. Secondary acute angle closure as
2/3GMS Ophthalmology Cases 2019, Vol. 9, ISSN 2193-1496
Silva et al.: Unilateral leukemic infiltration and acute angle closure ...
a manifestation of leukemic infiltration is very rare, with
only two other cases previously described in the literature
[6], [8]. In one of the cases, the patient already had an
established diagnosis of AML at the time of visual symp-
toms and presented with bilateral disease [8]. In the
other case, the patient was in remission for several years
and presented with unilateral disease [6], making the
diagnosis more challenging as in our case.
Our patient’s case also had the particularity of a challeng-
ing differential diagnosis given that our patient was under
maintenance chemotherapy and had history of a tubercu-
losis infection in the previous year. Therefore, alternative
diagnostic hypothesis such as endogenous endophthal-
mitis and ocular tuberculosis had to be excluded as well,
especially given that the patient was clinically in remis-
sion. Themicrobiologic exam and PCR forMycobacterium
tuberculosis were negative and the finding of leukemic
cells in the vitreous and anterior chamber was diagnostic.
Treatment of leukemic ocular infiltration comprises sys-
temic chemotherapy, but if this is not an option or if the
ocular disease is not responsive, ocular radiationmay be
combined [2], [6], typically with a total dose of 20 Gy [9].
Usually, it responds very well to systemic treatment, pre-
venting the need for enucleation or evisceration [2], [5],
[6], [7]. In our case, radiation therapy and chemotherapy
improved the patient’s symptoms and decreased the
intraocular mass. Initial visual acuity of absence of light
perception at presentation suggests prolonged ocular
involvement prior to the diagnosis hindering any possibility
of visual recovery.
Findings of ocular leukemic relapse should prompt a new
systemic work-up by the oncology team. Even though our
patient still has not developed any signs of systemic
leukemic relapse, in some cases where ocular findings
were the only sign of leukemic relapse, bone marrow or
CNS relapse ensued in the following months [5].
This case report highlights ocular leukemic infiltration as
the first sign of leukemic relapse. A high suspicion index
should be kept in these patients, even if in clinical remis-
sion for several years. Secondary acute angle closure is
a less frequent presentation that can happen especially
in cases with extensive intraocular infiltration.
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